C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cardiovascular Research

• Publication date

  2014-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cvr/cvu211PMID 25239825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conclusion and Future Perspectives

  2015cited by this paper
• Proinsulin C-peptide prevents impaired wound healing by activating angiogenesis in diabetes.

  2015influential reference
• A review of anti-VEGF agents for proliferative diabetic retinopathy

  2014cited by this paper
• Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice.

  2014cited by this paper
• Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes

  2014cited by this paper
• Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

  2014cited by this paper
• Evidence for an interaction between proinsulin C-peptide and GPR146.

  2013cited by this paper
• The clinical utility of C-peptide measurement in the care of patients with diabetes

  2013cited by this paper
• C-Peptide Activates AMPKα and Prevents ROS-Mediated Mitochondrial Fission and Endothelial Apoptosis in Diabetes

  2013cited by this paper
• SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory

  2013cited by this paper
• Mechanisms of diabetic complications.

  2013cited by this paper
• In Vivo Quantitative Visualization Analysis of the Effect of C‐Peptide on Glomerular Hyperfiltration in Diabetic Rats by Using Multiphoton Microscopy

  2013cited by this paper
• Diabetic foot ulcers.

  2013cited by this paper
• SIRT1, p66(Shc), and Set7/9 in vascular hyperglycemic memory: bringing all the strands together.

  2013cited by this paper
• The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Summary and Future Directions

  2013cited by this paper
• Nitric oxide regulates cardiac intracellular Na+ and Ca2 + by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism☆

  2013cited by this paper
• C-Peptide: A Molecule Balancing Insulin States in Secretion and Diabetes-associated Depository Conditions

  2013cited by this paper
• Can C‐peptide mediated anti‐inflammatory effects retard the development of microvascular complications of type 1 diabetes?

  2013cited by this paper
• ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS

  2013cited by this paper
• AMPK, insulin resistance, and the metabolic syndrome.

  2013cited by this paper
• Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients

  2012cited by this paper
• Insulin-Induced Generation of Reactive Oxygen Species and Uncoupling of Nitric Oxide Synthase Underlie the Cerebrovascular Insulin Resistance in Obese Rats

  2012cited by this paper
• Proinflammatory Effects of C-Peptide in Different Tissues

  2012cited by this paper
• C-Peptide Reduces Mitochondrial Superoxide Generation by Restoring Complex I Activity in High Glucose-Exposed Renal Microvascular Endothelial Cells

  2012cited by this paper
• Insulin increases surface expression of TRPC6 channels in podocytes: role of NADPH oxidases and reactive oxygen species.

  2012cited by this paper
• C-Peptide Prevents Hyperglycemia-Induced Endothelial Apoptosis Through Inhibition of Reactive Oxygen Species–Mediated Transglutaminase 2 Activation

  2012cited by this paper
• Macrophages and angiogenesis: a role for Wnt signaling

  2012cited by this paper
• The clotting system – a major player in wound healing

  2012cited by this paper
• The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes

  2012influential reference
• Diabetic neuropathy: cellular mechanisms as therapeutic targets

  2011cited by this paper
• C-peptide reduces pro-inflammatory cytokine secretion in LPS-stimulated U937 monocytes in condition of hyperglycemia

  2011cited by this paper
• C-peptide, a novel inhibitor of lung inflammation following hemorrhagic shock.

  2011cited by this paper
• C-peptide reduces high-glucose-induced apoptosis of endothelial cells and decreases NAD(P)H-oxidase reactive oxygen species generation in human aortic endothelial cells

  2011cited by this paper
• C-Peptide as a Therapeutic Tool in Diabetic Nephropathy

  2010cited by this paper
• Role of GTPases in control of microvascular permeability.

  2010cited by this paper
• Beneficial effects of C-peptide on renal morphology in diabetic rats.

  2010cited by this paper
• Epigenetic phenomena linked to diabetic complications

  2010cited by this paper
• Proinsulin C-peptide antagonizes the profibrotic effects of TGF-beta1 via up-regulation of retinoic acid and HGF-related signaling pathways.

  2010cited by this paper
• Proinsulin C‐peptide prevents type‐1 diabetes‐induced decrease of renal Na+‐K+‐ATPase α1‐subunit in rats

  2010cited by this paper
• Role of insulin in regulation of Na+-/K+-dependent ATPase activity and pump function in corneal endothelial cells.

  2010cited by this paper
• Oxidative stress and diabetic complications.

  2010cited by this paper
• Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein

  2010cited by this paper
• Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?

  2009cited by this paper
• Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption.

  2009cited by this paper
• C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy.

  2009cited by this paper
• Cellular and physiological effects of C-peptide.

  2009cited by this paper
• The beneficial effects of C-Peptide on diabetic polyneuropathy.

  2009cited by this paper
• Proinsulin C-peptide Regulates Ribosomal RNA Expression*

  2009cited by this paper
• Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials

  2009cited by this paper
• Insulin exhibits short-term anti-inflammatory but long-term proinflammatory effects in vitro.

  2009cited by this paper
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species*

  2009cited by this paper
• C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes

  2009cited by this paper
• C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients

  2008cited by this paper
• Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells.

  2008cited by this paper
• Insulin and endothelial function: A brief review

  2008cited by this paper
• C-peptide as a mediator of lesion development in early diabetes--a novel hypothesis.

  2008cited by this paper
• Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-κB pathway

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Treatment of Type 2 Diabetes With Combined Therapy

  2008cited by this paper
• Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease.

  2007cited by this paper
• Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis.

  2007cited by this paper
• C-peptide is a bioactive peptide

  2007influential reference
• Pathophysiology of acute wound healing.

  2007cited by this paper
• The C‐peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin‐induced diabetic rats

  2007cited by this paper
• BMC Surgery BioMed Central

  2007cited by this paper
• Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients With Type 1 Diabetes and Their Role in Microvascular Complications

  2007cited by this paper
• Cellular internalization of proinsulin C-peptide

  2007cited by this paper
• C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes

  2006cited by this paper
• C-Peptide Signals via Gαi to Protect against TNF-α–Mediated Apoptosis of Opossum Kidney Proximal Tubular Cells

  2006cited by this paper
• C-peptide exerts antithrombotic effects that are repressed by insulin in normal and diabetic mice

  2006cited by this paper
• High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway.

  2006cited by this paper
• Faculty Opinions recommendation of VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin.

  2006cited by this paper
• Type 1 diabetes.

  2006cited by this paper
• C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells.

  2006cited by this paper
• C-Peptide Induces Vascular Smooth Muscle Cell Proliferation: Involvement of Src-Kinase, Phosphatidylinositol 3-Kinase, and Extracellular Signal-Regulated Kinase 1/2

  2006cited by this paper
• VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin

  2006cited by this paper
• Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects

  2006cited by this paper
• Human proinsulin C-peptide prevents proliferation of rat aortic smooth muscle cells cultured in high-glucose conditions

  2005cited by this paper
• The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats.

  2005cited by this paper
• Solution structure of human proinsulin C‐peptide

  2005cited by this paper
• Vascular risk factors and diabetic neuropathy.

  2005cited by this paper
• Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: Role of insulin and C‐peptide

  2005cited by this paper
• Association of reduced red blood cell deformability and diabetic nephropathy.

  2005cited by this paper
• Vascular risk factors and diabetic neuropathy.

  2005cited by this paper
• Relationship between C peptide and chronic complications in type-2 diabetes mellitus.

  2005cited by this paper
• The Proinsulin C-peptide—A Multirole Model

  2004cited by this paper
• C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients.

  2004cited by this paper
• C-Peptide Colocalizes with Macrophages in Early Arteriosclerotic Lesions of Diabetic Subjects and Induces Monocyte Chemotaxis In Vitro

  2004cited by this paper
• Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide.

  2004cited by this paper
• Retinopathy in diabetes.

  2004influential reference
• C-peptide and Retinal Microangiopathy in Diabetes

  2004cited by this paper
• C‐peptide prevents nociceptive sensory neuropathy in type 1 diabetes

  2004cited by this paper
• C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats.

  2004cited by this paper
• Proinsulin C‐Peptide Replacement in Type 1 Diabetic BB/Wor‐rats Prevents Deficits in Nerve Fiber Regeneration

  2003cited by this paper
• Diabetic foot ulcers.

  2003cited by this paper
• Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition.

  2003cited by this paper
• Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study.

  2003cited by this paper
• C‐peptide enhances insulin‐mediated cell growth and protection against high glucose–induced apoptosis in SH‐SY5Y cells

  2003cited by this paper
• Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats

  2003cited by this paper

• Gene-Edited Islet Cell Transplant Offers Hope for Type 1 Diabetes, Eliminating Need for Immunosuppression

  2026cites this paper
• Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study

  2025cites this paper
• Modern approaches to creating a microenvironment for islets of langerhanes in the pancreas in order to increase functional activity during transplantation

  2025cites this paper
• Involvement of C-peptide in the progression of type 2 diabetes mellitus through triglyceride-centered lipid metabolism.

  2025cites this paper
• Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment.

  2024cites this paper
• Decreased glucagon in diabetic peripheral neuropathy patients with long duration type 2 diabetes.

  2024cites this paper
• Transglutaminase 2 in diabetes mellitus: Unraveling its multifaceted role and therapeutic implications for vascular complications

  2024cites this paper
• Proinsulin C-peptide inhibits high glucose-induced migration and invasion of ovarian cancer cells.

  2024cites this paper
• C-Peptide Ameliorates Particulate Matter 2.5-Induced Skin Cell Apoptosis by Inhibiting NADPH Oxidation

  2024cites this paper
• C-peptide: an essential ally in microvascular complications of type 2 diabetes mellitus and obesity

  2024cites this paper
• Impact of Fat Distribution and Metabolic Diseases on Cerebral Microcirculation: A Multimodal Study on Type 2 Diabetic and Obese Patients

  2024cites this paper
• Simultaneous attenuation of hyperglycemic memory-induced retinal, pulmonary, and glomerular dysfunctions by proinsulin C-peptide in diabetes

  2023cites this paper
• Systemic C‐peptide supplementation ameliorates retinal neurodegeneration by inhibiting VEGF‐induced pathological events in diabetes

  2023cites this paper
• The Correlation Between C-Peptide and Severity of Peripheral Atherosclerosis in Type 2 Diabetes Mellitus

  2023cites this paper
• The association of serum C-peptide with the risk of cardiovascular events: a meta-analysis and systematic review

  2023cites this paper
• Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy

  2023influential citation
• Insulin Requirement and Complications Associated With Serum C-Peptide Decline in Patients With Type 1 Diabetes Mellitus During 15 Years After Diagnosis

  2022cites this paper
• Therapeutic Effects of Stem Cells for the Treatment of Diabetes Mellitus

  2022cites this paper
• Acetyl-CoA-carboxylase 1 (ACC1) plays a critical role in glucagon secretion

  2022influential citation
• Human C-peptide is a ligand of the elastin-receptor-complex and therewith central to human vascular remodelling and disease in metabolic syndrome

  2022cites this paper
• C-Peptide Promotes Cell Migration by Controlling Matrix Metallopeptidase-9 Activity Through Direct Regulation of β-Catenin in Human Endometrial Stromal Cells

  2022influential citation
• Recent Progress of Research Regarding the Applications of Stem Cells for Treating Diabetes Mellitus

  2022cites this paper
• The bidirectional association of C-peptide with cardiovascular risk in nondiabetic adults and patients with newly diagnosed type 2 diabetes mellitus: a retrospective cohort study

  2022cites this paper
• Polymer-Based Delivery of Peptide Drugs to Treat Diabetes: Normalizing Hyperglycemia and Preventing Diabetic Complications

  2022influential citation
• Histone deacetylase 3 inhibition alleviates type 2 diabetes mellitus-induced endothelial dysfunction via Nrf2

  2021cites this paper
• Standardization of Visible Kinetic Assay for the Estimation of Plasma Glucose by Glucose Oxidase and Peroxidase Method

  2021cites this paper
• White Matter Microstructural Abnormalities of the Visual Pathway in Type 2 Diabetes Mellitus: A Generalized Q-sampling Imaging Study.

  2021cites this paper
• Glutathione Peroxidase as an Oxidative Stress and Insulin Resistance Marker in a group of Egyptian Patients with Normoglycemic Sickle Cell Disease

  2021cites this paper
• Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness

  2021cites this paper
• Vitamin D deficiency and cardiovascular risk in type 2 diabetes population

  2021cites this paper
• Continuous stimulation of dual-function peptide PGLP-1-VP inhibits the morbidity and mortality of NOD mice through anti-inflammation and immunoregulation

  2021cites this paper
• C-Peptide as a Therapy for Type 1 Diabetes Mellitus

  2021influential citation
• C-Peptide Inhibits Decidualization in Human Endometrial Stromal Cells via GSK3β-PP1

  2020cites this paper
• Multiple Cell Signalling Pathways of Human Proinsulin C-Peptide in Vasculopathy Protection

  2020influential citation
• Activity-expression profiling of glucose-6-phosphate dehydrogenase in tissues of normal and diabetic mice.

  2020cites this paper
• Relationship of C-peptide levels to duration of Type 1 diabetes – A study from Sindh, Pakistan

  2020cites this paper
• Anti-metastatic effect of midazolam on melanoma B16F10 cells in the lungs of diabetic mice.

  2020cites this paper
• Modulation of Inflammatory Dynamics by Insulin to Promote Wound Recovery of Diabetic Ulcers

  2020cites this paper
• Elucidation of a Copper Binding Site in Proinsulin C-peptide and Its Implications for Metal-Modulated Activity.

  2020cites this paper
• C-peptide corrects hepatocellular dysfunction in a rat model of type 1 diabetes

  2020cites this paper
• Preserved C-peptide secretion in patients with type 1 diabetes and incipient chronic complications is associated with lower serum resistin and higher uric acid levels

  2020cites this paper
• Application of elastin-like biopolymer-conjugated C-peptide hydrogel against diabetic aortic dysfunction for systemic long-term delivery.

  2020cites this paper
• Anti-diabetic effects of bioactive peptides: recent advances and clinical implications

  2020cites this paper
• Application of elastin-like biopolymer-conjugated C-peptide hydrogel for systemic long-term delivery against diabetic aortic dysfunction

  2020cites this paper
• The effect of C-peptide on diabetic nephropathy: A review of molecular mechanisms.

  2019cites this paper
• Role Of C-Peptide In The Vasculature

  2019cites this paper
• Production of genetically modified pigs expressing human insulin and C-peptide as a source of islets for xenotransplantation

  2019cites this paper
• The vicious cycle between transglutaminase 2 and reactive oxygen species in hyperglycemic memory–induced endothelial dysfunction

  2019cites this paper
• Navigating Two Roads to Glucose Normalization in Diabetes: Automated Insulin Delivery Devices and Cell Therapy.

  2019cites this paper
• Insulin prevents pulmonary vascular leakage by inhibiting transglutaminase 2 in diabetic mice.

  2019cites this paper
• Preventive Effects of Thermosensitive Biopolymer-Conjugated C-Peptide against High Glucose-Induced Endothelial Cell Dysfunction.

  2019cites this paper
• Draft Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and Nitric Oxide

  2018influential citation
• The dual effect of C‐peptide on cellular activation and atherosclerosis: Protective or not?

  2018cites this paper
• The benzodiazepine anesthetic midazolam prevents hyperglycemia‐induced microvascular leakage in the retinas of diabetic mice

  2018cites this paper
• Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.

  2018cites this paper
• Proinsulin C‐peptide prevents hyperglycemia‐induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice

  2018cites this paper
• Protective effects of either C‐peptide or l‐arginine on pancreatic β‐cell function, proliferation, and oxidative stress in streptozotocin‐induced diabetic rats

  2018cites this paper
• Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy.

  2017cites this paper
• C-peptides for diagnostics and therapy: a veterinary medicine point of view.

  2017cites this paper
• Cysteamine prevents vascular leakage through inhibiting transglutaminase in diabetic retina.

  2017cites this paper
• C-peptide attenuates acute lung inflammation in a murine model of hemorrhagic shock and resuscitation by reducing gut injury

  2017cites this paper
• Essential Role of Transglutaminase 2 in Vascular Endothelial Growth Factor–Induced Vascular Leakage in the Retina of Diabetic Mice

  2016influential citation
• C-peptide protects against hyperglycemic memory and vascular endothelial cell apoptosis.

  2016cites this paper
• Chronic liquid nutrition intake induces obesity and considerable but reversible metabolic alterations in Wistar rats

  2016influential citation
• Myopathy in Type Ii Diabetes : Metabolic and Functional Study in Adult Male Albino Rats = الوهن العضلي في داء السكري من النوع الثاني : دراسة أيضية ووظيفية في ذكور الجرذان البيضاء البالغة

  2016influential citation
• The role of C-peptide in skeletal muscle

  2016influential citation
• Type 2 diabetes mellitus

  2015cites this paper
• Diabetesneuropati - : Vad är största risken för att utveckla diabetesneuropati och kan det förhindras med hjälp av läkemedelsbehandling?

  2015cites this paper
• Hot topics and networks in Cardiovascular Research.

  2015cites this paper
• Circulating Dipeptidyl Peptidase-4 Activity is Associated with Diabetic Retinopathy in Type 1 Diabetic Patients

  2015cites this paper
• Dammarenediol‐II Prevents VEGF‐Mediated Microvascular Permeability in Diabetic Mice

  2015cites this paper
• Therapeutic Effects of PPARα on Neuronal Death and Microvascular Impairment

  2015cites this paper
• C-peptide as a Therapy for Kidney Disease: A Systematic Review and Meta-Analysis

  2015cites this paper
• Edinburgh Research Explorer Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment

  year unknowncites this paper
• The Relationship Between HbA1c/C-Peptide Ratio and Ischemic Event in a Patient with Atrial Fibrillation: Retrospective Study Atriyal Fibrilasyonu Olan Hastalarda HbA1c/C-Peptid Oran ı ile İ skemik Olaylar Aras ı ndaki İ li ş ki: Retrospektif Çal ı ş ma

  year unknowncites this paper
• A NOVEL BIOMARKER TO PREDICT CONTRAST-INDUCED NEPHROPATHY AND THE REQUIREMENT FOR RENAL REPLACEMENT THERAPY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: C-PEPTIDE/HBA1C RATIO

  year unknowncites this paper